Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative. The goal is to identify the obstacles and challenges that prevent participation in anaplastic thyroid cancer clinical research, as well as the reasons for withdrawal or discontinuation. Insights gained from this study will ultimately benefit those with anaplastic thyroid cancer who may be invited to participate in clinical research in the years to come.
Study Type
OBSERVATIONAL
Enrollment
500
Number of anaplastic thyroid cancer patients who decide to enroll in a clinical study
Time frame: 3 months
Rate of anaplastic thyroid cancer patients who remain in a clinical study to completion
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.